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Proteolytic maturationMammalian cellular repressor of E1A-stimulated genes is a lysosomal glycoprotein implicated in cellular growth
and differentiation. The genome of the fruit ﬂy Drosophila melanogaster encodes a putative orthologue (dCREG),
suggesting evolutionarily conserved physiological functions of this protein. In D. melanogaster S2 cells, dCREG
was found to localize in lysosomes. Further studies revealed that intracellular dCREG is subject of proteolyticmat-
uration. Processing and turnover could be substantially reduced by RNAi-mediated silencing of cathepsin L. In
contrast to mammalian cells, lysosomal delivery of dCREG does not depend on its carbohydrate moiety. Further-
more, depletion of the putative D. melanogaster lysosomal sorting receptor lysosomal enzyme receptor protein
did not compromise cellular retention of dCREG. We also investigated the developmental consequences of
dCREG ablation in whole D. melanogaster ﬂies. Ubiquitous depletion of dCREG proved lethal at the late pupal
stage once a knock-down efﬁciency of N95% was achieved. These results demonstrate that dCREG is essential
for proper completion of ﬂy development.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Cellular repressor of E1A-stimulated genes (CREG) is a mammalian
glycoprotein implicated in diverse cellular processes. CREG has been
reported to antagonize E1A-mediated transcriptional activation and
cellular transformation [1], to inhibit cell division while promoting cell
differentiation [2,3], to regulate the ERK1/2 pathway during cardiac
hypertrophy [4,5], and to protect cells from apoptosis via activation of
the PI3K and JNK signaling pathways [6,7]. However, the molecular
mechanisms governing these physiological functions of CREG are still
a matter of debate.
The crystal structure of human CREG revealed that CREGmonomers
display a β-barrel fold and that CREG appears to form a homodimeric
complex. Its carbohydrate moiety has been shown to contain mannoseA-stimulated genes; dCREG,
RP, Lysosomal enzyme receptor
se CREG; PNGase F, Peptide
+43 1 47654 6392.
. This is an open access article under6-phosphate (M6P) residues [8]. All three potential N-glycosylation
sites are mapped on the surface opposite of the dimer interface,
and CREG thus potentially represents a multivalent ligand for
M6P receptors [9]. Our previous studies demonstrated that murine
CREG carries M6P residues at both N-glycosylation sites, and that
both M6P receptors are involved in its intracellular retention. In
murine ﬁbroblasts, CREG is residing in lysosomal compartments
and is proteolytically processed due to the action of lysosomal cys-
teine proteinases [10]. Interestingly, the genome of the fruit ﬂy
Drosophila melanogaster encodes a putative orthologue of CREG.
Like its human counterpart, D. melanogaster CREG (dCREG) shares
limited sequence homology to adenoviral E1A and binds in vitro
to D. melanogaster retinoblastoma protein [1]. However, its bio-
chemical properties and subcellular localization in D. melanogaster cells
have not been investigated as yet.
In mammals, the intracellular sorting pathways for newly synthe-
sized lysosomal proteins are well understood and depend mostly on
the action of two M6P receptors: the M6P/insulin-like growth factor
II receptor (M6P/IGF2R) and the 46-kDa M6P receptor (MPR46).
In the trans-Golgi network (TGN), these receptors bind proteins
carrying N-glycans modiﬁed with M6P groups. The receptors are
then concentrated in membrane buds via interaction of theirthe CC BY license (http://creativecommons.org/licenses/by/3.0/).
2901E. Kowalewski-Nimmerfall et al. / Biochimica et Biophysica Acta 1843 (2014) 2900–2912cytoplasmic tails with adaptor proteins like the heterotetrameric adap-
tor protein (AP) complexes and the monomeric Golgi-localizing, γ-ear-
containing, ARF-binding proteins (GGAs). These complexes are then
concentrated in clathrin-coated vesicles which then bud from the
TGN, carrying the cargo proteins to endosomal compartments [11–13].
Biosynthetic sorting of lysosomal enzymes inD. melanogaster cells is far
less understood. Protein transport to D. melanogaster lysosomes appears to
be independent of the M6P recognition marker, although a putative
phosphotransferase homologue has been identiﬁed in the ﬂy genome
[14]. Interestingly, recent studies have identiﬁed a D. melanogaster protein,
lysosomal enzyme receptorprotein (LERP),which is closely related toM6P/
IGF2R. The luminal domain of LERP consists of ﬁve repeating domains,
which contain potential carbohydrate-binding regions. However, it has
been shown that LERP is unable to bind M6P residues [15]. Recently, it
was demonstrated that intracellular trafﬁcking of LERP in D. melanogaster
cells is dependent on GGA, and that LERP depletion leads to decreased
processing of lysosomal cathepsin L [16]. Furthermore, LERP expression
was found to rescue the missorting of lysosomal proteins in M6P
receptor-deﬁcient mouse ﬁbroblasts [15]. However, direct interaction
between LERP and lysosomal proteins has not been observed so far.
In this study, we report a detailed characterization of the bio-
synthesis and subcellular localization of dCREG in D. melanogaster
S2 cells. Furthermore, the impact of LERP on the intracellular trans-
port and proteolytic maturation of dCREG was investigated. Finally,
we examined the consequences of RNAi-mediated knock-down of
dCREG in ﬂies.
2. Materials and methods
2.1. Antibodies
Recombinant dCREG and LERP produced in insect cells were puriﬁed
as described below and then used to immunize rabbits (Gramsch
Laboratories, Schwabenhausen, Germany). Antibodies were puriﬁed
by afﬁnity chromatography with immobilized recombinant proteins as
reported [10,17], using 0.1 M glycine/HCl buffer (pH 2.3) for elution.
Recombinant D. melanogaster Golgi α-mannosidase II [18] was kindly
provided by Douglas Kuntz (University of Toronto, Canada) and used
to prepare antibodies in mice. Mouse monoclonal antibodies to
α-tubulin (Sigma-Aldrich), insect cathepsin L (R&D Systems, Minneap-
olis, MN) and the V5 epitope (Invitrogen, Carlsbad, CA) were purchased
from commercial suppliers.
2.2. Construction of pMT vectors
All oligonucleotide primers used in this study were custom-
synthesized by Sigma-Aldrich (St. Louis, MO), and restriction enzymes
were purchased from Fermentas (St. Leon-Rot, Germany). For am-
pliﬁcation of the dCREG coding sequence, total RNA was extracted
from D. melanogaster S2 cells using the RNeasy kit (Qiagen, Venlo,
Netherlands) according to the instructions of the supplier. dCREG
cDNA was then generated using the OmniScript kit (Qiagen) with the
following primers: 5′-ATGAAAACCTTTCACTCCCTACTATTC-3′ (sense)
and 5′-TCAATTCGAAACAGCGTAATAGTCAG-3′ (antisense). The
resulting 636-bp PCR fragment was then cloned into pMT/V5-His-
TOPO (Invitrogen), yielding pMT/dCREG. The dCREG cDNA was
also cloned into the KpnI and XhoI sites of pMT/V5His after ampliﬁ-
cation with 5′-TTGGGTACCATGAAAACCTTTCACTCCCTACTATCC-3′
(sense) and 5′-TTACTCGAGATTCGAAACAGCGTAATAGTCAG-3′ (an-
tisense), resulting in pMT/dCREG-V5His. Construction of the
dCREG-GFP vector was performed by transferring the GFP sequence
from pEGFP-N3 (BD Biosciences, Erembodegem, Belgium) into the
NotI and SacII sites of pMT/dCREG-V5His, giving rise to pMT/
dCREG-GFP-V5His. To mutate the single N-glycosylation site of
dCREG (Asn87) into Gln, the Quick-Change site-directed mutagene-
sis kit (Stratagene, La Jolla, CA) was used with 5′-AGCGATGCTAATCAAAGGTCCACTGGAC-3′ (sense) and 5′-GTCCAGTGGACCTTTGATTA
GCATCGCT-3′ (antisense) as primers.
2.3. Construction of other expression vectors
A cDNA fragment encoding dCREG lacking its signal peptide was
obtained by PCR using the primers 5′-AGCTCTAGATACTCCCGCCGG
AAAGATG-3′ (sense) and 5′-GTAGGTACCTCAATTCGAAACAGCGTA
ATAGTCAG-3′ (antisense). The PCR product was cleaved with XbaI
and KpnI at the underlined sites and ligated into pVTBacHis-1
baculovirus transfer vector [19], digested with the same enzymes.
In this construct, the recombinant protein is placed downstream of
the melittin signal peptide, a hexahistidine sequence and an Xpress
epitope (Asp-Leu-Tyr-Asp-Asp-Asp-Asp-Lys). To replace the latter
by a FLAG epitope (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys), pVTBacHis-
1 was subjected to site-directed mutagenesis with the primers 5′-GACA
GCAAATGGGTCGGGATTACAAGGACGATGACGATAAGTC-3′ (sense) and
5′-GACTTATCGTCATCGTCCTTGTAATCCCGACCCATTTGCTGTC-3′ (anti-
sense), giving rise to pVT-BacHis-FLAG. A cDNA fragment encoding the
LERP ectodomain (amino acids 42–781) was ampliﬁed using the primers
5′-AATCTAGAGACGCAGCCAATCAGC-3′ (sense) and 5′-AATCTAGATCAG
AGGGAAAGGAACTCGC-3′ (antisense), cleaved with XbaI at the
underlined sites and then ligated into pVTBacHis-FLAG. To generate the
expression plasmid pFO4/dCREG, ampliﬁcation of a cDNA encoding a
truncated version of dCREG lacking the N-terminal signal peptide was
achieved by PCR using the primers 5′-CACAGATCTTACTCCCGCCG-3′
(sense) and 5′-GCAGAATTCTCAATTCGAAACAGCG-3′ (antisense). The
corresponding mouse CREG cDNA fragment was obtained with the
primers 5′-AAAGGATCCCGCGGAGGCCGGGACCACG-3′ (sense) and 5′-
CCCGAATTCTCACTGCAGCGTGACGTTAAAATATTCTTCAG-3′ (antisense).
The PCR products were digested with EcoRI and BglII or BamHI and then
ligated into the EcoRI and BamHI sites of pFO4/hCREG (kindly provided
by Michael Sacher, Biotechnology Research Institute, Montreal, Canada).
pFO4/dCREG has an open reading frame consisting of a short leader
sequence (Met-Gly-Ser-Ser-His-His-His-His-His-His-Gly-Ser) followed
by dCREG residues 24–212, while pFO4/msCREG encodes amino acids
32–220 of mouse CREG fused to the same N-terminal tag.
2.4. Cell culture and transfection
D. melanogaster S2 cells (Invitrogen)weremaintained in Schneider's
insect medium supplemented with 10% FBS, 50 units/ml penicillin and
50 μg/ml streptomycin at 27 °C. S2 cells were transfected using theDro-
sophila Expression System (Invitrogen)with a 30:1 ratio of the pMT/V5-
His expression constructs and pCoBlast (Invitrogen). Stably transfected
cells were obtained by selection with 30 μg/ml blasticidin (Invitrogen).
Blasticidin-resistant clones were obtained after 10–14 days and propa-
gated in the presence of 10 μg/ml blasticidin.
2.5. Gene silencing experiments in S2 cells
For synthesis of target-speciﬁc double-stranded RNA, fragments
were ampliﬁed by PCR with gene-speciﬁc primers ﬂanked by T7 pro-
moter sites at the 5′ end. The resulting fragments were used as tem-
plates for in vitro transcription performed with the HiScribe RNAi
Transcription Kit (New England Biolabs, Beverly, MA) following the
manufacturer's instructions. The following gene-speciﬁc primer se-
quences were used for double-stranded RNA preparation: 5′-CACCAA
GTACGGCAACAATG-3′ (cathepsin L, sense); 5′-TAGACGCCCTCCGAGT
AGAA-3′ (cathepsin L, antisense); 5′-GATGCAAGGCAACCACCTAT-3′
(LERP, sense); 5′-CGGCACAGCCTAATTGGTAT-3′ (LERP, antisense). S2-
dCREG cells were seeded at a density of 2 × 106 cells in 1 ml serum-
free medium, to which 15 μg double-stranded RNA was added. After
60 min, 1 ml serum-containing medium was added to the cells prior
to incubation for 72 h at 27 °C.
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Spodoptera frugiperda Sf9 and Sf21 cells (both obtained from the
American Type Culture Collection, Manassas, VA) were grown in
IPL-41 medium containing 5% heat-inactivated FBS, 50 units/ml peni-
cillin and 50 μg/ml streptomycin at 27 °C. pVTBacHis-1/dCREG or
pVTBacHis-FLAG/LERP (1 μg)was cotransfectedwith 200 ngBaculoGold
viral DNA (BD Biosciences) into Sf9 cells using Lipofectin (Invitrogen) as
recommended by the manufacturer. Supernatant containing recombi-
nant baculovirus was harvested after 5 days and used for infection of
Sf21 cells.
2.7. Puriﬁcation of recombinant proteins produced in insect cells
Culture supernatants (200 ml) of Sf21 cells infected with recombi-
nant baculovirus were cleared by centrifugation and dialyzed two
times against 2 L of dialysis buffer (10 mM sodium phosphate buffer,
pH 7.0, 40 mM NaCl, 0.02% NaN3). The supernatant was supplemented
with 20 mM imidazole and 10% (v/v) glycerol and then loaded on a
5 ml column of Chelating Sepharose (GE Healthcare, Little Chalfont,
United Kingdom) charged with Ni2+ ions, equilibrated in the same
buffer. After successive washes with 40 mM and 80 mM imidazole,
the recombinant protein was eluted with 250 mM imidazole in dialysis
buffer. Protein-containing eluate fractions were pooled and dialyzed
twice against 1 L of PBS containing 0.02% (w/v)NaN3 prior to concentra-
tion by ultraﬁltration and addition of proteinase inhibitors (1mMPMSF,
5 μg/ml E-64 and 5 μg/ml leupeptin). Recombinant LERP was further
puriﬁed by loading on a 1 ml Anti-FLAGM2 afﬁnity column (Sigma-Al-
drich). The columnwas washed with 10 ml PBS containing 0.02% NaN3.
Bound LERP was then eluted with 5 ml 100 μg/ml FLAG peptide in the
same buffer. The eluate fractions were pooled, dialyzed and then con-
centrated as above.
2.8. Puriﬁcation of recombinant proteins produced in Escherichia coli
E. coli BL21 (DE3) cells (Invitrogen) transformed with pFO4/CREG
were grown in 1 L of LB medium containing 100 μg/ml ampicillin at
37 °C until an optical density at 600 nm of 0.6 was reached. Re-
combinant protein production was then induced by addition of 1 mM
IPTG. After induction, the cells were cultured for 16 h at 30 °C. The
bacterial cells were harvested by centrifugation, resuspended in 20 ml
lysis buffer (50 mM Tris/HCl, 1 mM PMSF, pH 8.0), and disintegrated
by ultrasonication. After centrifugation of the lysates for 20 min at
15,000 ×g and 4 °C, the supernatant was adjusted to 0.3 M NaCl,
10 mM imidazole and 5% (v/v) glycerol, and loaded onto a 1 ml column
of His-Select beads (Sigma-Aldrich), equilibrated in the same buffer
without glycerol. After extensive washing with equilibration buffer,
the recombinant protein was eluted with 250 mM imidazole in equili-
bration buffer. Protein-containing eluate fractionswere pooled and dia-
lyzed twice against 1 L of PBS containing 0.02% (w/v) NaN3.
2.9. Size exclusion chromatography
The quaternary structure of recombinant CREG was examined by
size exclusion chromatography on a Superdex 75 HR 10/30 column
(GE Healthcare) equilibrated with 50 mM sodium phosphate buffer
(pH 7.0) containing 150 mM NaCl, using an ÄKTA puriﬁer system (GE
Healthcare). Elution was performed with a ﬂow rate of 0.5 ml/min,
and the absorbance of the eluate was recorded at 280 nm.
2.10. Circular dichroism spectroscopy
Circular dichroism spectroscopywas performed at 25 °C on a PiStar-
180 spectrometer (Applied Photophysics, Leatherhead, United
Kingdom). The instrument was ﬂushed with nitrogen at a ﬂow rate of
5 L permin. For recording of far UV spectra (180–260 nm), recombinantproteins dissolved in 5 mM sodium phosphate buffer (pH 7.0) were
brought to identical concentrations as determined by measuring the
optical density of the solutions at 280 nm. Each spectrumwas automat-
ically corrected for the birefringence of the cell.
2.11. In vitro processing of CREG by cathepsins B and L
In vitro processing assays were carried out in 10 μl 50 mM sodium
acetate buffer (pH 5.5) containing 2 mM cysteine. 100 ng recombinant
human cathepsin B [20] or cathepsin L (kindly provided by John Mort,
Shriners Hospital for Children, Montreal, Canada) were added to 2 μg
recombinant mouse CREG or dCREG and incubated for 30 min to 16 h
at 37 °C. The reaction was stopped by addition of SDS-PAGE sample
buffer containing 50 μg/ml E-64 and subsequent heating for 5 min at
95 °C.
2.12. Cleavage site analysis
N-terminal sequence analysis of bands blotted onto PVDF mem-
branes (Bio-Rad) as described previously [21] was performed by
Edman degradation on an Applied Biosystems Procise 492 protein
sequencer (Protein Micro-Analysis Facility, Medical University of
Innsbruck, Austria). dCREG treated with cathepsin L was also cha-
racterized by LC-electrospray ionization-MS, either as intact protein or
after digestion with trypsin or chymotrypsin subsequent to separation
by SDS-PAGE [22]. The samples were fractionated by nano-LC
(150 × 0.32 mm BioBasic-18, Thermo Scientiﬁc, Waltham, MA) using a
gradient of 1–80% acetonitrile. On-line data acquisition was conducted
in positive-ion mode on a maXis-4GQ-TOF mass spectrometer (Bruker,
Billerica,MA).MS2 scans of dominant precursor peaksweremanually an-
alyzed with Data Analysis software version 4.0 (Bruker).
2.13. Preparation of microsomal extracts
1 × 108 S2-dCREG cells were harvested with a cell scraper, washed
with PBS, resuspended in 1ml 3mM imidazole buffer (pH 7.4) contain-
ing 0.25 M sucrose and lysed by 20 strokes with a tight-ﬁtting pestle
using a Dounce homogenizer. Postnuclear supernatants were obtained
by low-speed centrifugation (5 min at 400 ×g) and then centrifuged
for 60 min at 105,000 ×g and 4 °C. The pellets were extracted for
30 min at 0 °C with 250 μl 50 mM Tris/HCl (pH 7.4), 150 mM NaCl,
1 mM PMSF, 5 μg/ml leupeptin, 5 μg/ml E-64 and 0.1% Triton X-100.
The samples were then cleared by centrifugation for 10 min at
15,000 ×g prior to further analysis.
2.14. Secretion studies
2 × 106 S2-dCREG cells were washed with PBS and then incubated
for 72 h at 27 °C in 2 ml of culture medium containing 0.5 mM CuSO4.
The conditioned media were then aspirated and cleared by low-speed
centrifugation (5 min, 320 ×g) and subsequent passage through 0.22-
μm ﬁlters. After washing with PBS and harvesting by scraping, cells
were sonicated (3 × 10 s) in 250 μl 50 mM Tris/HCl (pH 7.4) containing
150mMNaCl, 1mMPMSF, 5 μg/ml leupeptin and 5 μg/ml E-64. Prior to
extraction at 0 °C for 30min, Triton X-100 was added to a ﬁnal concen-
tration of 1%. Samples were cleared by centrifugation for 10 min at
15,000 ×g and subjected to SDS-PAGE and immunoblotting analysis.
2.15. Fluorescence microscopy
S2 cells expressing dCREG-GFP were plated on acid-washed glass
coverslips treated with 0.5 mg/ml concanavalin A (Sigma-Aldrich) and
then induced for 16 hwith 0.5mMCuSO4 prior to ﬁxation by incubation
for 10min in 4% paraformaldehyde in PBS. After blockingwith PBS con-
taining 0.2% BSA or 3% normal goat serum in PBS for 1 h, the cells were
incubated for 1 h with monoclonal anti-insect cathepsin L (5 μg/ml) or
Fig. 1. Posttranslational modiﬁcation of dCREG by proteolytic maturation and
N-glycosylation. (A) D. melanogaster S2 cells overexpressing dCREG under the control of
the metallothionein promoter (S2-dCREG) were incubated for 72 h in the presence of
0.5 mM CuSO4. Cell lysates (C; 6 μg) and media (M) corresponding to 0.15 μg cellular pro-
tein were treated for 1 h in the presence (+) or absence (−) of PNGase F. Proteins were
then subjected to immunoblotting analysiswith antibodies to dCREG. (B) S2 cells express-
ing V5His-tagged dCREG (S2-dCREG-V5His) and S2 cells expressing V5His-tagged,
N-glycosylation-minus dCREG (S2-dCREG-Nmut-V5His) were incubated for 72 h in the
presence of 0.5 mM CuSO4. Cell extracts (C; 6 μg) and conditioned media
(M) corresponding to 0.15 μg cellular protein were incubated with (+) or without (−)
PNGase F as outlined above, immunoblotted and probed with antibodies to dCREG. The
migration positions of selected molecular mass standards are indicated. The results
shown are representative of three independent experiments.
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(1:500) diluted with PBS containing 0.2% BSA and 0.1% saponin. After
a second blocking step in PBS containing 0.1% saponin and 5% FBS
(1 h), bound primary antibodies were detected by incubation for 1 h
with Cy3-conjugated afﬁnity-puriﬁed secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) used at a concentration of 5 μg/ml
in PBS containing 5% FBS and 0.1% saponin. All steps were performed
at room temperature. The immunostained cells were examined with a
Leica TCS SP5 confocal microscope equipped with Ar and He/Ne lasers.
Images from the confocal system were deconvoluted using Huygens
Essential 3.7 software (Scientiﬁc Volume Imaging, Hilversum,
Netherlands) and then imported into Adobe Photoshop CS 8.0 for
coloration. For staining of acidic organelles, S2 cells stably express-
ing dCREG-GFP were induced as above and then incubated in medi-
um supplemented with 100 nM LysoTracker Red DND-99 (Molecular
Probes, Eugene, OR). Cells were incubated for 30 min at 27 °C, then
brieﬂy rinsed with PBS and immediately observed by confocal
laser-scanning microscopy. Lysotracker staining of fat bodies isolat-
ed from timed third-instar larvae (age: 92 h) was done as above for
5 min at room temperature prior to confocal imaging of 5–10 tissue
areas per sample.
2.16. Maintenance of ﬂy strains
The following lines were used: Canton-S, Oregon-R, w1118 (wild-
type); the double-balancer If/Cyo; Sb/TM3, Ser; the ubiquitously
expressed driver da-GAL4 (Bloomington Stock Center, Bloomington,
IN); UAS-CREG-RNAiKK (line: 108999), UAS-cathepsin L-RNAiKK
(110619), UAS-cathepsin B-RNAiKK (108315), VDRC (Vienna, Austria);
Lsp2-GAL4-UAS-GFP-Atg8 [23]. Animals were reared at 18 °C or 25 °C
on regular ﬂy food (10% corn meal, 2.25% dried yeast, 1.25% soya ﬂour,
2.75% molasses, 10% malt extract, 1.05% agar, 0.8% propionic acid and
0.175% nipagin A). Crosses were performed by standard procedures.
2.17. Generation of UAS-dCREG-GFP ﬂies
dCREG-GFP-V5His cDNA was ampliﬁed by PCR from the pMT/
dCREG-GFP-V5His vector using the following primers: 5′-TAAGAAT
TCATGAAAACCTTTCACTCCCTAC-3′ (sense) and 5′-AAGACTAGTCTAA
TGGTGATGGTGATGATG-3′ (antisense). The resulting PCR product was
then cloned into the EcoRI and SpeI sites (underlined) of pUASTattB
(provided by Peter Duchek, Institute of Molecular Biotechnology, Vien-
na, Austria). Transgenic ﬂies were then generated using a ΦC31-based
integration system, leading to targeted insertion of the ectopic sequence
on the third chromosome (VDRC, Vienna, Austria).
2.18. Preparation of ﬂy extracts
Freshly eclosed ﬂies were resuspended in 50 μl extraction buffer
(50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1 mM PMSF, 5 μg/ml
leupeptin, 5 μg/ml E-64 and 1% Triton X-100) per ﬂy and then thor-
oughly ground with a micropestle. The samples were then placed on
ice for 30 min and subsequently cleared by centrifugation for 10 min
at 15,000 ×g and 4 °C.
2.19. Temperature-shift experiments
w1118 and UAS-CREG-RNAi; da-GAL4 ﬂies were reared at 18 °C, put
on fresh medium and then shifted to 25 °C. Parents were removed
from the vials after 5 days at the latest. Eclosed ﬂies were counted as
well as late pupae that did not hatch even after 20 days of cultivation.
As a control, w1118 and UAS-CREG-RNAi; da-GAL4 ﬂies were kept at
18 °C and counted as above. To account for the longer life cycle at
18 °C, numbers of ﬂies and pupae were recorded for up to 6 weeks. In
total, 600–1000 ﬂies and pupae were counted for every condition.2.20. Other methods
Enzymatic deglycosylation of proteins, SDS-PAGE, immunoblotting
andmass spectrometric N-glycan analysis were performed as previous-
ly described [10]. Total protein content was determined either with the
Bio-Rad protein assay kit or the BCA protein assay kit (Pierce, Rockford,
IL) as appropriate, using BSA as a standard. Statistical analyseswere per-
formedusing Student's t-test,with p b 0.05 being considered signiﬁcant.
3. Results
3.1. dCREG is posttranslationally modiﬁed by N-glycosylation and limited
proteolysis
Human CREG is a homodimeric protein [9]. Elucidation of the qua-
ternary status of dCREG produced in E. coli by means of size exclusion
chromatography revealed that, like human CREG, the insect protein is
a dimer with an approximate native molecular mass of 41 kDa. Recom-
binant dCREG was also subjected to an evaluation of its structural fea-
tures by circular dichroism spectroscopy. dCREG shows the typical
properties of a β-sheet protein combined with α-helical elements and
thus displays a similar secondary structure as human CREG (data not
shown).
Recombinant dCREG produced in the baculovirus expression system
wasused to raise a rabbit antiserum.Monospeciﬁc antibodieswere then
isolated with the aid of immobilized dCREGmade in E. coli. Immunoblot
analysis of D. melanogaster S2 cells revealed that endogenous dCREG
was hardly detectable in crude lysates. For further studies, we therefore
decided to overexpress dCREG cDNA in S2 cells under the control of an
inducible promoter to minimize overloading of the endogenous sorting
machinery. This approach allowed the detection of intracellular dCREG
as four bands ranging from 19 to 23 kDa, whereas two bands of 20
and 22 kDa were observed for the secreted fraction of the protein
(Fig. 1A).
Human and mouse CREG are N-glycosylated [2,10], and dCREG con-
tains one potential N-glycosylation site at position Asn87. To examine if
the D. melanogaster protein is indeed posttranslationally modiﬁed with
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cells were treated with peptide N-glycosidase F (PNGase F). Digestion
with PNGase F resulted in a reduction of the apparent molecular mass
of both cellular and secreted dCREG (Fig. 1A), verifying that the protein
indeed carries N-linked oligosaccharides. Deglycosylation reduced the
apparent molecular mass of the secreted 22-kDa band to 20 kDa, thus
indicating that the two dCREG variants present in the culture medium
correspond to the glycosylated and carbohydrate-free forms of the
same polypeptide. Analysis of the amino acid sequence of dCREG with
SignalP 4.0 [24] identiﬁed the ﬁrst 23 amino acids as potential
N-terminal signal sequence for targeting to the secretory pathway.
Hence, the predicted molecular mass of dCREG is 21.6 kDa, which is in
reasonable agreement with our experimental data. The bands of 20
and 22 kDa corresponding to the secreted forms of dCREG were also
present in cell extracts, in addition to two other variants of 19 and
23 kDa. After PNGase F treatment, the 19-kDa band migrated as a
17-kDa polypeptide while the molecular mass of the 23-kDa form was
reduced to 20 kDa (Fig. 1A). The detection of the 17-kDa polypeptide
after enzymatic deglycosylation suggests that intracellular dCREG is
not only processed by signal peptidase but also subject of additional
N-terminal proteolyticmaturation like its human andmouse orthologues
[10,25]. For the 23-kDa band, conversion into the 20-kDa polypeptide
was also observed upon digestionwith endoglucosaminidase H, whereas
the other forms of dCREG were not sensitive to this more restrictive
endoglycosidase (data not shown). This indicates that 23-kDa dCREG
carries high-mannose N-glycan precursors and thus most likely repre-
sents a biosynthetic intermediate located in the endoplasmic reticulum.
In contrast, the dCREG species of 19 and 22 kDa are modiﬁed with fully
processed paucimannosidic oligosaccharide structures as typical for gly-
coproteins that have passed through the insect Golgi apparatus [26].Fig. 2. CREG can be proteolytically processed by lysosomal cysteine proteinases. (A) Recombina
Samples were then analyzed by SDS-PAGE followed by Coomassie Brilliant Blue staining. (
N-terminally tagged dCREG produced in E. coli (30 ng) was subjected to in vitro processing by
blotting with antibodies to dCREG. The migration positions of selected molecular mass standarThe exclusive presence of paucimannosidic N-glycans on secreted
dCREGwas veriﬁed bymass spectrometric analysis of the puriﬁed recom-
binant protein produced in insect cells (data not shown).
To analyze if N-glycosylation of dCREG is important for intracellular
retention and biosynthetic sorting of the protein, we prepared a
glycosylation-minus variant by replacing Asn87 with Gln by site-
directed mutagenesis. S2-dCREG-V5His and S2-dCREG-Nmut-V5His
cells (stably expressingwild-type or Asn87→Gln dCREG, bothmodiﬁed
with a C-terminal V5His-tag) were generated and then analyzed by im-
munoblotting. Interestingly, dCREG-Nmut-V5His was still retained by
the cells and also subject of proteolytic processing. Despite overexpres-
sion of the mutant protein which could cause excessive secretion, the
extent of its intracellular retention was 5.5 ± 1.3%, which was even
higher than for wild-type dCREG-V5His (1.1± 0.1%; p= 0.029). Treat-
ment with PNGase F shifted the 19-kDa and 27-kDa bands of wild-type
dCREG-V5His to their unglycosylated counterparts of 17 and 25 kDa,
whereas bands of dCREG-Nmut-V5His were, as expected, not sensitive
to PNGase F treatment and co-migrated with the deglycosylated wild-
type proteins (Fig. 1B). In addition, dCREG-Nmut-V5His displayed a
prominent 19-kDa band which was barely detectable in wild-type
dCREG-V5His treated with PNGase F. Like the 25-kDa full-length pro-
tein, this 19-kDa polypeptide reacted with anti-V5 antibodies, whereas
the wild-type and mutant 17-kDa forms failed to do so (data not
shown). This suggests that the 19-kDa variant of dCREG-Nmut-V5His
is a processing intermediate which has undergone N-terminal proteo-
lytic maturation but still carries the C-terminal V5His-tag. While
C-terminal processing of intracellular dCREG-Nmut-V5His was less efﬁ-
cient than in the case of its wild-type counterpart, removal of the
N-terminal propeptide (73 ± 2%) was even more pronounced than for
the wild-type protein (42 ± 3%; p = 0.001). Collectively, these datantmouse CREG (msCREG) and dCREGwere incubated with cathepsins B or L for up to 4 h.
B) Microsomal extracts of S2-dCREG cells (10 μg) were deglycosylated with PNGase F.
cathepsin L for 4 h. The samples were separated by SDS-PAGE and analyzed by immuno-
ds are indicated.
Fig. 3. Effects of RNAi-mediated knock-down of cathepsin L on dCREG processing and
turnover in S2 cells. S2-dCREG cells were induced with 0.5 mM CuSO4 and incubated
with double-stranded (ds) cathepsin L RNA for 72 h. Untreated cells cultivated under
the same conditions were used as controls. Cell lysates (6 μg) were deglycosylated with
PNGase F and subjected to SDS-PAGE. Immunoblottingwas then performedwith antibod-
ies to dCREG and cathepsin L. Tubulin served as loading control. Band intensities were
determined by densitometry. Data are expressed asmeans of 3 independent experiments.
Themigration positions of selectedmolecularmass standards are indicated. proCREG, full-
length dCREG; CREG, processed dCREG; proCL, procathepsin L; mCL, mature cathepsin L.
*p ≤ 0.001 (comparison of knock-down cells and controls).
2905E. Kowalewski-Nimmerfall et al. / Biochimica et Biophysica Acta 1843 (2014) 2900–2912indicate that the presence of an N-glycan is dispensable for transport of
dCREG to its intracellular destination and subsequent proteolytic pro-
cessing of the protein in this compartment.
3.2. dCREG can be processed by lysosomal cysteine proteinases
Our previously published studies revealed that maturation of CREG
in murine ﬁbroblasts involves the action of lysosomal cysteine cathep-
sins [10]. Four of these enzymes (cathepsins B, F, L and K) have been
identiﬁed in S2 cells by a functional proteomics screen [27]. Recently,
Eissenberg et al. [16] showed that cathepsin L (74%) and cathepsin B
(21%) account together for more than 90% of the cysteine proteinase
activity of S2 cells. To investigate if cathepsins B and L are capable of
processing CREG, we performed in vitro processing assays using recom-
binantmouse CREG (msCREG) and dCREG as substrates. Both CREGpro-
teins could be processed by either enzyme, leading to a ﬁnal processing
product of about 18 kDa (msCREG) and17 kDa (dCREG), respectively. In
both cases, cathepsin L was much faster in processing than cathepsin B
(Fig. 2A). This is in good agreement with cathepsin L being a far more
potent endopeptidase than cathepsin B which primarily acts as a
dipeptidyl carboxypeptidase [28]. For comparison of dCREG processed
by cathepsin L in vitrowith the endogenous forms of the protein occur-
ring in S2 cells, immunoblotting analysis of in vitro digested dCREG and
deglycosylated extracts of S2-dCREG cells was performed. This revealed
that the cathepsin L cleavage product co-migrates with the mature in-
tracellular protein (Fig. 2B).
Given this evidence that cathepsin L could be involved in dCREG
processing in vivo, the N-terminal sequence of recombinant dCREG in-
cubated with cathepsin L in vitro was determined by Edman degrada-
tion. The processed protein was found to be missing its 14 N-terminal
residues. Since cathepsin L is strictly acting as an endopeptidase [28],
it can be inferred that the K14–R15 bond is preferentially cleaved
(EYK14↓R15EQEL). This was conﬁrmed by MS analysis, which also re-
vealed minor amounts of further truncated sequences starting with
E16, Q17 and E18. Interestingly, the N-terminal processing site corre-
sponds closely to that of cathepsin L in msCREG (DVD12↓R13RLPP) and
to the authentic N-terminus of mature human CREG (DEASR14↓L15PP
[25]). MS analysis also demonstrated that recombinant dCREG does
not undergo C-terminal processing when exposed to cathepsin L (data
not shown). This suggests that the same applies to the mature protein
accumulating within cells, which is in good agreement with our previ-
ous ﬁndings for endogenous CREG in mouse ﬁbroblasts [10].
3.3. Cathepsin L is involved in dCREG turnover and processing in vivo
Intracellular processing of dCREG was further analyzed using RNAi-
mediated depletion of cathepsin L in S2 cells. The knock-down efﬁcien-
cy was determined by immunoblotting. Only 3 ± 1% residual immuno-
reactive cathepsin L could be detected after the double-stranded RNA
treatment (Fig. 3). This almost quantitative removal of cathepsin L led
to a 1.8 ± 0.1-fold higher dCREG accumulation (p b 0.001) in S2-
dCREG cells and signiﬁcantly reduced the extent of intracellular
dCREG processing from 34 ± 2% to 18 ± 1% (p = 0.001). Although
these results clearly show that endogenous cathepsin L is involved in
turnover and processing of dCREG, other cellular proteinases are appar-
ently also engaged in the latter process. Similar observationsweremade
for the proteolyticmaturation of endogenous CREG inmouseﬁbroblasts
[10].
3.4. Intracellular dCREG is a lysosomal protein
To assess the subcellular localization of dCREG in S2 cells, confocal
ﬂuorescence microscopy was performed. S2 cells were stably
transfected with a cDNA construct encoding a chimeric protein
consisting of GFP fused to the C-terminus of dCREG (dCREG-GFP).
dCREG-GFPwas detected in vesicles dispersed throughout the cytoplasm,a subcellular distribution reminiscent of endosomes and lysosomes. Live-
cell staining of S2-dCREG-GFP cells with Lysotracker Red showed that a
substantial fraction of dCREG-GFP is located in acidic compartments.
Moreover, double-labeling experiments revealed a large extent of co-
localization between dCREG-GFP and cathepsin L. In contrast, the subcel-
lular distribution of dCREG-GFP did not overlap with that of Golgi-
mannosidase II (Fig. 4). These ﬁndings clearly show that intracellular
dCREG is an endosomal/lysosomal protein in S2 cells.
3.5. LERP depletion does not affect intracellular retention of dCREG by S2
cells
In mammals, receptor-mediated sorting to lysosomes largely
depends on the speciﬁc recognition of lysosomal proteins by M6P
receptors. Recently, an M6P receptor homologue named lysosomal en-
zyme receptor protein (LERP) has been identiﬁed in D. melanogaster.
Heterologous expression of LERP inM6P receptor-deﬁcientmurine em-
bryonic ﬁbroblasts led to a partial rescue of lysosomal enzyme
misrouting [15]. When overexpressed in S2 cells, LERP was localized
in trans-Golgi compartments and interacted with the clathrin adaptors
GGA and AP-1 [29,30]. However, the endogenous forms of this protein
have not been characterized so far. For detection of endogenous LERP,
a soluble form of the protein (amino acids 42–781) was produced in
the baculovirus expression system and used to raise antibodies in rab-
bits. Immunoblotting analysis of total S2-dCREG extracts with antibod-
ies to recombinant LERP revealed two bands of 135 and 115 kDa. Both
bands were sensitive to PNGase F resulting in an increase of the respec-
tive electrophoretic mobility by approximately 10 kDa in either case.
Fig. 4. dCREG co-localizes with lysosomal markers. S2 cells stably transfected with a cDNA construct encoding GFP fused to the C-terminus of dCREG (dCREG-GFP) were stained with
Lysotracker Red and analyzed by live-cell imaging (top). S2 cells expressing dCREG-GFP were ﬁxed, permeabilized and incubated with antibodies to cathepsin L (middle) or Golgi-
mannosidase II (GMII; bottom). Bound antibodies were then detected with Cy3-labeled secondary antibodies followed by confocal laser-scanning microscopy. Co-localization was
assessed by merging of the individual images. Bars, 10 μm.
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ity of the antiserum (Fig. 5A).
To assess if LERP is involved in intracellular retention of dCREG, we
performed knock-down experiments in S2-dCREG cells. The extent of
LERP depletion achieved in these experiments amounted to 72 ± 1%
(Fig. 5A). Consistent with the notion that LERP could contribute to theFig. 5. LERP is not critical for lysosomal sorting of dCREG. (A) S2-dCREG cells were treated with
ditions were used as controls. Cell lysates (12 μg) were treated with PNGase F prior to immuno
determined by densitometry. Data are expressed as normalized means of three independent ex
(dCREG) or 1.2 μg (cathepsin L) cellular protein were analyzed by immunoblotting with the in
full-length dCREG; CREG, processeddCREG; proCL, procathepsin L;mCL,mature cathepsin L. The
are representative of three independent experiments.sorting of lysosomal enzymes in ﬂies [15], retention of cathepsin L was
moderately reduced in LERP-depleted cells (57 ± 1%) as compared to
sham-treated controls (66 ± 1%; p = 0.002). Interestingly, maturation
of dCREG was found to be slightly less effective when S2-dCREG cells
were subjected to LERP-RNAi (27 ± 2% mature dCREG as compared to
32 ± 1% in the controls; p = 0.057). This could be due to the reduceddouble-stranded (ds) LERP RNA for 72 h. Untreated cells cultivated under the same con-
blotting with antibodies to LERP. Tubulin served as loading control. Band intensities were
periments. (B) Cell lysates (C; 6 μg) and conditioned media (M) corresponding to 0.15 μg
dicated antibodies after enzymatic deglycosylation where appropriate (dCREG). proCREG,
migration positions of selectedmolecularmass standards are indicated. The results shown
Fig. 6. Cathepsin L knock-down impairs turnover of dCREG in vivo. Extracts from
daughterless-GAL4 (da-GAL4) × w1118 (control), da-GAL4 N UAS-CB-RNAiKK and da-
GAL4 N UAS-CL-RNAiKK ﬂies were immunoblotted and probed with antibodies to dCREG
(top), cathepsin L (middle) and tubulin as loading control (bottom). Band intensities
were determined by densitometry. The cathepsin L and dCREG contents of the respective
knock-down ﬂies were calculated relative to control animals. Data are expressed asmeans
of four independent experiments. The migration positions of selected molecular mass
standards are indicated. proCREG, full-length dCREG; CREG, processed dCREG; CL, cathep-
sin L; CB, cathepsin B.
2907E. Kowalewski-Nimmerfall et al. / Biochimica et Biophysica Acta 1843 (2014) 2900–2912cathepsin L content of LERP-depleted cells. However, the efﬁciency of
dCREG retention (1.7 ± 0.3%) was not lower than in control cultures
(1.0 ± 0.1%; Fig. 5B). We also investigated whether LERP could directly
bind dCREG in vitro, using differentially tagged recombinant proteins.
No speciﬁc interaction could be observed under any of the conditions
tested (data not shown). These data suggest that LERP is dispensable
for intracellular retention of dCREG, indicating that LERP is, unlike its
mammalian relatives, not a universal sorting receptor for lysosomal
proteins in ﬂies.
3.6. Cathepsin L is required for turnover of dCREG in D. melanogaster ﬂies
Using UAS-RNAi and GAL4-driver lines, we also investigated the
consequences of depletion of cathepsins B or L on the processing status
and the protein levels of dCREG in whole animals. UAS-cathepsin
B-RNAi, UAS-cathepsin L-RNAi and the wild-type strain w1118 were
crossed with the ubiquitous daughterless-GAL4 (da-GAL4) driver line.
Extracts of hemizygous, freshly eclosed females and males were then
analyzed by immunoblotting. Interestingly, knock-down of cathepsin L
in male ﬂies was more efﬁcient (86 ± 6%) than in female ﬂies (64 ±
16%) resulting in an increased total dCREG content of 722 ± 190%
(males; p b 0.05) and 316 ± 53% (females; p b 0.01). In contrast, and
consistent with our in vitro results (Fig. 2A), turnover of dCREG was
much less affected in cathepsin B-depleted ﬂies: dCREG levels
amounted to 161 ± 19% (p b 0.05) in males and 118 ± 18% in females
when compared to control (da-GAL4 × w1118) animals. However,
dCREG processing was not compromised in the knock-down ﬂies
(Fig. 6). These results further emphasize that cathepsin L is the major
proteinase in D. melanogaster responsible for the turnover of dCREG,
with some contributions also by cathepsin B.
3.7. dCREG is essential for D. melanogaster development
In order to create a stable dCREG knock-down ﬂy line, UAS-CREG-
RNAi and da-GAL4 lines were crossed with double balancers (If/CyO;
Sb/TM3, Ser) to obtain UAS-CREG-RNAi; Sb/TM3, Ser and If/CyO; da-
GAL4 ﬂies. These were then crossed to generate UAS-CREG-RNAi/CyO;
da-GAL4/TM3, Ser offspring. By crossing the latter with each other, we
obtained ﬂies homozygous for both UAS-CREG-RNAi and da-GAL4. We
assumed that themost efﬁcient dCREG knock-downwould be achieved
in such double homozygous ﬂies. Moreover, we exploited the reduced
activity of GAL4 at 18 °C [31] to maintain the double homozygous
stock. To induce strong dCREG depletion, we shifted UAS-CREG-RNAi;
da-GAL4 ﬂies cultivated at 18 °C to 25 °C, resulting in lethality at late
pupal stage (only 3% of all pupae eclosed). When control w1118 ﬂies
were shifted from 18 °C to 25 °C, 98% of all pupae eclosed. When
grown at 18 °C, 89% of UAS-CREG-RNAi; da-GAL4 and 97% of w1118
ﬂies eclosed (Fig. 7A).
To addresswhether dCREG knock-downwas enhanced by increased
incubation temperature and RNAi cassette/driver copy numbers, the
relative dCREG content of the respective ﬂy extracts was determined
by immunoblotting. At 18 °C, the dCREG level in UAS-CREG-RNAi/
CyO; da-GAL4/TM3, Ser (1 × RNAi, 1 × driver) amounted to 59 ± 9%,
in UAS-CREG-RNAi; da-GAL4/TM3, Ser (2 × RNAi, 1 × driver) to 40 ±
4% and in UAS-CREG-RNAi; da-GAL4 (2 × RNAi, 2 × driver) to 30 ±
2%. When ﬂies were reared at 25 °C, however, knock-down was much
more efﬁcient. The dCREG content was already reduced to 14 ± 7% in
UAS-CREG-RNAi/CyO; da-GAL4/TM3, Ser ﬂies, while in UAS-CREG-
RNAi; da-GAL4/TM3, Ser ﬂies the residual dCREG content was deter-
mined as 13 ± 4% (Fig. 7B). As already mentioned above, hardly any
double homozygous ﬂies could be obtained from crosses maintained
at 25 °C. Thus, efﬁcient dCREG depletion is necessary to cause lethality
at the pupal stage.
In order to conﬁrm that the observed lethality is not the conse-
quence of off-target effects of the RNAi sequence used, we recombined
a UAS-CREG-GFP construct with da-GAL4 on the third chromosome(If/CyO; da-GAL4 N UAS-CREG-GFP) and crossed the resulting line
with UAS-CREG-RNAi; Sb/TM3, Ser ﬂies. The expression of dCREG-GFP
in these recombined ﬂies was veriﬁed by immunoblotting, revealing
that the majority of the dCREG-GFP fusion protein is cleaved into its
constituents. This leads to a more than 100 times higher dCREG content
of dCREG-GFP overexpressing ﬂies as compared to da-GAL4 controls
(Fig. 8A). Counting offspring of UAS-CREG-RNAi/CyO; da-GAL4/TM3,
Ser and UAS-CREG-RNAi/CyO; da-GAL4 N UAS-CREG-GFP/TM3, Ser
ﬂies cultivated at 25 °C showed that simultaneous overexpression of
dCREG-GFP cDNA partially rescued dCREG knock-down lethality, as
demonstrated by an increase in surviving double homozygous animals
from 1 ± 1% to 9 ± 1%. The successful rescue becomes even more evi-
dent when the number of ﬂies carrying one copy of UAS-CREG-RNAi
and two copies of the da-GAL4 driver is compared with that of the cor-
responding rescue ﬂies (0% and 26± 1% of the expected respective off-
springnumbers). It should bepointed out that our dCREG-GFP construct
is also a target of the dCREG-RNAi sequence used in this study, which
probably explains why a full rescue could not be achieved. Notably,
the dCREG content of the rescued ﬂies corresponded only to 8% of that
of da-GAL4 controls (Fig. 8B). Similar results were obtainedwith anoth-
er, independently generated dCREG rescue line. Taken together, these
results demonstrate that dCREG is essential for proper ﬂy development
once the level of this protein is reduced to below 8% of the normal
amount. This compares well to lysosomal enzyme deﬁciencies in man,
where restoration of 10–15% of the missing hydrolase activity is often
sufﬁcient to correct the respective clinical phenotype.
In D. melanogaster, the functionality of the lysosomal compartment
is studied best in the fat bodies of third-instar larvae (the deve-
lopmental stage preceding pupation). In these organs, the starvation-
induced generation of autolysosomes is readily detectable by live-cell
imaging with Lysotracker Red [23,32]. While pronounced dye accumu-
lation was observed in most control samples (82%), the fraction of
Lysotracker-positive da-GAL4 N UAS-CREG-RNAi sections (31%) was
Fig. 7. dCREG depletion in D. melanogaster ﬂies. (A) Double homozygous UAS-CREG-RNAi; da-GAL4 andwild-type (w1118) ﬂies were propagated at 18 °C or shifted to 25 °C and supplied
with freshmedia daily for 5 consecutive days. The percentage of eclosed ﬂies was calculated. (B) CREG knock-down efﬁciency is dependent on temperature and gene dosage. Control (da-
GAL4) and UAS-CREG-RNAi/CyO; da-GAL4/TM3, Ser ﬂies were grown at 18 °C or 25 °C. Freshly eclosed ﬂies were subjected to immunoblotting analysis with antibodies to dCREG and
tubulin as loading control. Relative dCREG levels were determined by densitometry. Data are expressed as means of three independent experiments.
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body-speciﬁc GAL4 driver (Lsp2) was used. Whereas the vast majority
of wild-type tissues displayed strong Lysotracker staining (88%), such
a response was only seen in less than half (43%) of the dCREG-
depleted specimens. However, sequestration of GFP-Atg8 into punctate
structures was similar in Lsp2-GAL4-UAS-GFP-Atg8 × UAS-CREG-RNAi
and control fat bodies, demonstrating that dCREG knock-down does
not impair autophagosome formation (Fig. 10). Moreover, the median
survival time of starved da-GAL4 N UAS-CREG-RNAi larvae (42 h) was
the same as that of control animals. Since disruption of autophagy
genes is known to cause hypersensitivity to starvation in
D. melanogaster [32], these results indicate that dCREG depletion
does not interfere with the induction of a robust autophagic
response.
4. Discussion
This report demonstrates that dCREG is an endosomal/lysosomal
glycoprotein, which undergoes proteolytic maturation during itsbiosynthesis similar to its mammalian counterparts. Our previous
study showed that murine CREG co-localizes with the lysosomal en-
zymes cathepsin B and cathepsin D in ﬁbroblasts [10]. To determine
the subcellular localization of dCREG in S2 cells, we ﬁrst showed sub-
stantial co-localization between dCREG-GFP and a lysosomotropic dye
by live-cell microscopy.We have also observed co-localization between
dCREG and cathepsin L, a lysosomal protein inD.melanogaster cells [33].
Mammalian CREG undergoes limited processing upon delivery to
lysosomes. Our previous study revealed that inhibition of lysosomal cys-
teine cathepsins in murine ﬁbroblasts leads to accumulation of a pro-
cessing intermediate, but the proteinases involved in this maturation
event could not be identiﬁed [10]. In humans, 11 cysteine cathepsins
have been found (cathepsins B, C, F, H, K, L, O, S, V,W and Z). Cathepsins
F, K, L, S and V appear to be obligate endopeptidases, whereas cathep-
sins B and H display exopeptidase as well as endopeptidase activities.
Two genuine exopeptidases also belong to this family, the dipeptidyl
aminopeptidase cathepsin C and the carboxypeptidase cathepsin Z
[28]. Four of these enzymes (cathepsins B, F, K and L) have been also de-
tected inD.melanogaster [27].We have nowobserved that cathepsin L is
Fig. 8. Rescue of dCREG knock-down ﬂies by dCREG-GFP expression. (A) Lysates of
da-GAL4 (control) and If/CyO; da-GAL4 N UAS-CREG-GFP ﬂies were immunoblotted
with antibodies to dCREG and tubulin as loading control. (B) Progeny of UAS-CREG-
RNAi/CyO; da-GAL4/TM3, Ser and UAS-CREG-RNAi/CyO; da-GAL4 N UAS-CREG-GFP/
TM3, Ser was counted (500–1000 ﬂies per assay). Data from three independent
experiments are expressed as means ± SE. Lysates from control, dCREG knock-down
(UAS-CREG-RNAi; da-GAL4/TM3, Ser) and rescue ﬂies (UAS-CREG-RNAi; da-
GAL4 N UAS-CREG-GFP) ﬂies were subjected to immunoblot analysis with antibodies to
dCREG and tubulin as loading control.
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recombinant dCREG digested with cathepsin L co-migrated with the
mature polypeptide present in S2 extracts. N-terminal sequencing of
dCREG treated with cathepsin L revealed the removal of the ﬁrst 14
amino acids. A similar processing event has been described for human
monocytes, where also a truncated form of CREG lacking its 14 N-
terminal amino acids has been detected [25]. Further support for the in-
volvement of cathepsin L in dCREG maturation was obtained by RNAi-
mediated downregulation of the enzyme. Knock-down of this cysteine
proteinase led to enhanced accumulation and partially impaired pro-
cessing of dCREG in S2 cells. Moreover, reduced turnover of dCREG
could also be observed upon cathepsin L depletion in whole ﬂies.
These results strongly support the notion that proteolytic cleavage of
dCREG takes place after reaching endosomal/lysosomal compartments
due to an endoproteolytic cleavage event which can be executed by ca-
thepsin L. As demonstrated for cathepsin B, other lysosomal proteinases
are probably also capable of removing the dCREG propeptide, thus
explaining why dCREG processing is only partially impaired upon al-
most quantitative depletion of cathepsin L.
Previous studies have shown that mammalian CREG interacts with
both M6P receptors, M6P/IGF2R and MPR46 in an M6P-dependent
manner [8–10]. Our studies clearly show that intracellular retention of
dCREG does not rely on N-glycosylation of the protein, indicating that
carbohydrate–protein interactions are not involved in its delivery to
lysosomes. Only very few protein-based lysosomal sorting signals
have been identiﬁed so far, most of them in plants [34]. However, a
recent study reported a carbohydrate-independent mode of action for
the binding of human CREG to M6P/IGF2R domains 11–15, a fragment
of the receptor which does not harbor a functional M6P-binding site
[35]. Sequence alignments have revealed that its D. melanogaster rela-
tive LERP is homologous to receptor domains 9–13 [15]. This led us to
testwhether dCREG could bind to LERP via protein–protein interactions.
However, our pull-down experiments did not provide any evidence for
LERP being capable of directly associating with dCREG. Moreover,
downregulation of LERP did not impede lysosomal sorting of dCREG in
S2 cells, indicating that this putative lysosomal sorting receptor is not
engaged in the delivery of dCREG to its intracellular destination. Note-
worthy, our knock-down studies conﬁrmed that LERP depletion leads
to reduced intracellular retention of cathepsin L and thus reduced lyso-
somal cysteine proteinase activity as previously reported [16]. This ﬁnd-
ingprovides a potential explanation for the slightly impaired proteolytic
processing of intracellular dCREG upon LERP depletion in S2 cells, since
cathepsin L appears to be involved in this maturation step.
In order to learn more about the physiological role of dCREG in
D. melanogaster, we decided to investigate the consequences of dCREG
depletion in this genetically tractable model organism. We could dem-
onstrate that dCREG knock-down is lethal at late pupal stages. Impor-
tantly, rescue experiments conﬁrmed that the observed pupal lethality
is indeed due to dCREG depletion. Interestingly, manifestation of this
phenotype appears to be associated with changes to the autolysosomal
compartment. Although CREG has not yet been implicated in autopha-
gy, recent studies have linked this protein to many other physiological
processes such as cell migration [36,37], replicative senescence [38], ap-
optosis [39], cell cycle progression [35] and proliferation [40]. However,
a unifying concept which reconciles all these proposed functions of
CREG has not beenput forward so far. The interpretation of the available
data on the putative cellular activities of CREG is also complicated by
seemingly contradictory results reported in different studies. In smooth
muscle cells, CREG has been found to inhibit migration [36] and to in-
duce cell cycle arrest [35]. The opposite has been observed for endothe-
lial cells, where overexpression of CREG led to enhanced mobility [37]
and accelerated proliferation [40]. In this context, it is also of note that
we were unable to conﬁrm the anti-apoptotic potential of CREG report-
ed for smoothmuscle andmesenchymal stem cells [6,7,39] in other cel-
lular systems (E. Kowalewski-Nimmerfall and L. Mach, unpublished
results). Hence, the molecular mechanism accounting for the pupal
Fig. 9. Reduced Lysotracker accumulation in fat bodies of dCREG knock-down ﬂies. Control (da-GAL4 × Canton-S) and da-GAL4 N UAS-CREG-RNAi larvae were either starved for 4 h or
further maintained on regular food (fed). Fat bodies were then removed and stained with Lysotracker Red prior to analysis by confocal laser-scanning microscopy. Bars, 20 μm.
Fig. 10. Autophagosome formation is not impaired in dCREG knock-down ﬂies. Control (Lsp2-GAL4-UAS-GFP-Atg8 × Canton-S) and Lsp2-GAL4-UAS-GFP-Atg8 × UAS-CREG-RNAi larvae
were either starved for 4 h or further maintained on regular food (fed). Fat bodies were then removed and stained with Lysotracker Red. Acidic compartments (Lysotracker) and
autophagosomes (GFP-Atg8) were detected by confocal laser-scanning microscopy. Co-localization was assessed by merging of the individual images. Bars, 20 μm.
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elucidated.
This study was the ﬁrst to assess the role of CREG in a living animal.
To our knowledge, this is also the ﬁrst report demonstrating that down-
regulation of a luminal lysosomal protein can cause developmental
lethality inD. melanogaster. It is worth pointing out that the information
available on the consequences of depleting individual lysosomal
enzymes in ﬂies is still scarce. So far, such studies have been only per-
formed for a small number of acid hydrolases. Ablation of the cathepsin
L gene has been shown to result in female sterility. Attenuated pigmen-
tation of some abdominal segments was also observed. Other visible
morphological effects include the appearance of the wings, which
often contain bubbles and frequently fail to expand fully [41]. In-
activation of cathepsin D in ﬂies results in age-dependent neuro-
degeneration and recapitulates the key features of neuronal ceroid
lipofuscinoses, a family of lysosomal storage disorders [42]. Genetic
analysis inD.melanogaster also revealed that cathepsin D plays a neuro-
protective role by counteracting tau-induced neurotoxicity [43]. Simi-
larly, mutations in the FDL gene encoding an endosomal/lysosomal
β-N-acetylglucosaminidase affect normal development of the ﬂy brain,
resulting inmajor anatomical changes to themushroom bodies asman-
ifested by fused lobe structures [44]. Having established that dCREG is
essential for proper completion of ﬂy development, our results set the
stage for D. melanogaster becoming the model organism of choice for
future studies on the physiological functions of this lysosomal protein.
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